Project Grant HT94252410817
Award Date 7/15/24
Completion Date 7/14/26
Dollars Obligated $588K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- The Department of Defense, through the Military Medical Research and Development program (CFDA 12.420), awarded a $467,742 Project Grant to the Regents of the University of Michigan to optimize a risk stratification model for ovarian cancer. The award will support research activities from September 1, 2024 through August 31, 2026. The University of Michigan, a top public research institution, has extensive experience conducting federal research and development projects for agencies such as the...
- The University of Michigan will receive $782,729 from the Department of the Army Medical Command under a Project Grant award through the Military Medical Research and Development program (CFDA 12.420) to improve outcomes for women with ovarian cancer. The four-year award beginning September 1, 2022 will support research to transform healthcare for Service Members and the public through innovative medical solutions for the battlefield and investigation of solutions for ovarian cancer. The...
- The Defense Health Agency awarded a $312,000 Project Grant to the Regents of the University of Michigan to support research determining a role for PP2A in the development and treatment of endometriosis. The grant period runs from January 15, 2023 to January 14, 2025. The research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through...
- Federal Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $248,156 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the identification of molecular biomarkers for invasive glioblastoma cell states and tumor microenvironment modulation. The award, effective October 1, 2025, through September 30, 2027, supports advanced biomedical...
- This Project Grant award of $546,000.00 from the Defense Health Agency supports research at the Regents of the University of Michigan to develop a novel lectin for targeting T-cell lymphomas. The award is part of the Military Medical Research and Development program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for service members and the public through innovative and impactful research. The 3-year award began on September 1, 2023 and will...
- The Department of Defense's Defense Health Agency awarded a $1,100,747 Project Grant on April 1, 2025 to the Regents of the University of Michigan to conduct research on "Protein Engineering of Antibody-Drug Conjugates to Coordinate the Innate and Adaptive Immune Systems for Curative Responses" under the Military Medical Research and Development program (CFDA 12.420). This research aims to develop innovative medical solutions that address critical health challenges relevant to military...
- Federal Grant Award Summary The University of Michigan's Regents received a $537,536 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective November 1, 2025, through October 31, 2028. The award supports research titled "Targeting Mycobiome Metabolism to Reprogram the Immunosuppressive Pancreatic Tumor Microenvironment," to be conducted at the University of Michigan's Ann Arbor campus. This three-year...
- The University of Michigan received a $925,834 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program. The grant will fund research into CDK12 as a context-specific tumorigenesis regulator and novel therapeutic target in castration-resistant prostate cancer. The research will be performed in Ann Arbor, Michigan over a three-year period from September 2021 through August 2024. Through the support of basic,...
- Federal Grant Award Summary The Regents of the University of Michigan received a $448,133 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period November 1, 2025 through October 31, 2028. The award supports research titled "Targeting Mycobiome Metabolism to Reprogram the Immunosuppressive Pancreatic Tumor Microenvironment," conducted at the University of Michigan's Ann Arbor campus. This project...
- Federal Project Grant Award Summary The University of Michigan, through its Office of Research and Sponsored Projects, received a $1.84M Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. This research initiative, titled "CoTargeting NSD1/2 Paralogs in AR-Driven Castration-Resistant Prostate Cancer," supports advanced biomedical research focused on developing...